Better Choice Parking

Better Choice Research Partner, Aimia Pet HealthCo Inc., Signs Second R&D Partnership Agreement with KGK Science for Development of GLP1 Supplement for Pets

Retrieved on: 
Thursday, November 16, 2023
Pet, Better Choice Parking, Cat, NYSE, KGK, Overweight, Consultant, Obesity, Animal, GLP1, Dog, APH, MOU

TAMPA, Fla., Nov. 16, 2023 (GLOBE NEWSWIRE) -- Better Choice Company (NYSE: BTTR) (“Better Choice” or the “Company”), a pet health and wellness company, today announced its research partner, Aimia Pet HealthCo.

Key Points: 
  • TAMPA, Fla., Nov. 16, 2023 (GLOBE NEWSWIRE) -- Better Choice Company (NYSE: BTTR) (“Better Choice” or the “Company”), a pet health and wellness company, today announced its research partner, Aimia Pet HealthCo.
  • Inc. (APH), has signed a memorandum of understanding (MOU) with KGK Science Inc. (KGK) for the development of a GLP1 supplement for pets.
  • The MOU sets out the basis for KGK to commence research and development of a GLP1 supplement for use in companion animals.
  • KGK is a leading Canadian researcher organization that provides high-quality clinical research trials and expert regulatory support to several industries.

BETTER CHOICE COMPANY, INC. ANNOUNCES THIRD QUARTER 2023 RESULTS

Retrieved on: 
Monday, November 13, 2023
Sale, Growth, Better Choice Parking, NYSE, GAAP, Adjustment, Halo, YOY, Video game

TAMPA, FLORIDA, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Better Choice Company, Inc. (“Better Choice” or the “Company”) (NYSE American: BTTR), a pet health and wellness company, today announced its results for the third quarter ended September 30, 2023 (“Q3 2023”).

Key Points: 
  • TAMPA, FLORIDA, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Better Choice Company, Inc. (“Better Choice” or the “Company”) (NYSE American: BTTR), a pet health and wellness company, today announced its results for the third quarter ended September 30, 2023 (“Q3 2023”).
  • Revenue increased 24% from second quarter 2023, and 11% year-over-year (“YOY") to $13.1 million
    1 Adjusted EBITDA is a non-GAAP measure.
  • Better Choice generated $13.1 million in net sales over Q3 2023, with approximately 75% driven by its Halo Holistic® product line.
  • Point-of-sale2 growth and strength of digital presence drove 24% revenue growth from the second quarter of 2023.

Lavior, a Leader in Rapid Healing Diabetic Wound Care, is Now Available at Walmart Nationwide, Endorsed by The American Diabetes Association

Retrieved on: 
Tuesday, December 12, 2023
Skin, Black, Research, BIPOC, Disease, Risk, Amputation, American Diabetes Association, Better Choice Parking, Walmart, Wound healing, Standard of care, Diabetes, Partnership, Hospital, Quality of life, Inula, Pharmaceutical industry, MIAMI

MIAMI, Dec. 12, 2023 /PRNewswire-PRWeb/ -- Lavior, the company exclusively offering comprehensive over-the-counter diabetic wound and skin treatments, announces its Diabetic Hydrogel Wound Dressing and Diabetic First Aid Gel plant-based creams are now at Walmart nationwide. The American Diabetes Association (ADA) has endorsed the Diabetic Wound Gel with its Better Choices for Life mark for their efficacy, evidence-based research and ability to manage complications of diabetes in the initial stages.

Key Points: 
  • MIAMI, Dec. 12, 2023 /PRNewswire-PRWeb/ -- Lavior , the company exclusively offering comprehensive over-the-counter diabetic wound and skin treatments, announces its Diabetic Hydrogel Wound Dressing and Diabetic First Aid Gel plant-based creams are now at Walmart nationwide.
  • The American Diabetes Association (ADA) has endorsed the Diabetic Wound Gel with its Better Choices for Life mark for their efficacy, evidence-based research and ability to manage complications of diabetes in the initial stages.
  • "As experts in rapid-healing diabetic wound care, we offer a practical solution for at-home diabetic care," said Gilad.
  • "As experts in rapid-healing diabetic wound care, we offer a practical solution for at-home diabetic care," said Gilad.

Diabetic Tussin Reintroduces Sugar-Free Cold and Cough Solution for People with Diabetes

Retrieved on: 
Wednesday, November 29, 2023
Cough, RSV, National Diabetes Education Program, Congestion, Risk, Better Choice Parking, Prestige Consumer Healthcare, American Diabetes Association, Fructose, Sorbitol, Mucus, COVID-19, Dollar, Blood, Diabetes, Prediabetes, Sodium, Pharmaceutical industry, Amazon

TARRYTOWN, N.Y., Nov. 29, 2023 /PRNewswire/ -- Today, Diabetic Tussin®, the trusted cough syrup brand for people with diabetes and prediabetes, announces its sugar-free cold and cough solution is back on shelves. This restock brings with it the Better Choices for Life mark from the American Diabetes Association® (ADA). This over-the-counter cold and cough solution returns just as the threat of a 'tripledemic' — when cases of COVID-19, flu, and RSV surge at the same time—looms over American households.

Key Points: 
  • TARRYTOWN, N.Y., Nov. 29, 2023 /PRNewswire/ -- Today, Diabetic Tussin®, the trusted cough syrup brand for people with diabetes and prediabetes, announces its sugar-free cold and cough solution is back on shelves.
  • This over-the-counter cold and cough solution returns just as the threat of a 'tripledemic' — when cases of COVID-19, flu, and RSV surge at the same time—looms over American households.
  • "Diabetic Tussin is an essential over-the-counter cold and cough solution for millions of Americans concerned about ingredients in other products that can raise blood sugar levels.
  • Made with the strongest sugar-free formula on the market, Diabetic Tussin Max allows consumers to effectively manage their cough and cold symptoms with the right ingredients.

Lavior Diabetic Creams Launch at Walmart During National Diabetes Month

Retrieved on: 
Tuesday, November 14, 2023
Savyon, Skin, Black, Research, Extremities, Entrepreneurship, BIPOC, Disease, Risk, American Diabetes Association, Walmart, Better Choice Parking, Patient, Amputation, Infection, African Americans, Health, Diabetes, Burns, Death, Quality of life, Environment, Inula, Pharmaceutical industry, Grocery store, MIAMI

MIAMI, Nov. 14, 2023 /PRNewswire-PRWeb/ -- Lavior Pharma, an expert in rapid-healing diabetic wound care, announces the launch of its Diabetic Hydrogel Wound Dressing and Diabetic First Aid Gel plant-based creams at Walmart, coinciding with National Diabetes Month. Lavior is the only company offering a comprehensive line of over-the-counter diabetic wound and skin treatments. The American Diabetes Association (ADA) has endorsed the creams with its Better Choices for Life mark for their efficacy, evidence-based research, and ability to manage complications of diabetes.

Key Points: 
  • MIAMI, Nov. 14, 2023 /PRNewswire-PRWeb/ -- Lavior Pharma , an expert in rapid-healing diabetic wound care, announces the launch of its Diabetic Hydrogel Wound Dressing and Diabetic First Aid Gel plant-based creams at Walmart, coinciding with National Diabetes Month.
  • The American Diabetes Association (ADA) has endorsed the creams with its Better Choices for Life mark for their efficacy, evidence-based research, and ability to manage complications of diabetes.
  • With its minimally invasive creams, the brand's all-in-one solutions help people with diabetes handle common side effects associated with the disease.
  • Lavior is now available in 3,000 Walmart stores nationwide and on Walmart.com for less than $20 for a 30-day supply.

Better Choice Research Partner, Aimia Pet HealthCo Inc., Signs R&D Partnership Agreement for Development of GLP1 Supplement for Pets

Retrieved on: 
Wednesday, November 8, 2023
Faculty, NYSE, São Paulo, Federal University of Rio Grande do Sul, Obesity, Cat, Université de Montréal Faculty of Veterinary Medicine, Pet, Doctor of Philosophy, Rio, UNESP, APH, Veterinary medicine, MOU, Medical school, Faculty of Medicine, University of Colombo, University of São Paulo, UFRGS, Animal, University, Universidad, Overweight, Better Choice Parking, Pain management, GLP1, Dog, MS, Physiology, Medicine, Pharmacology, Anesthesia

TAMPA, Fla., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Better Choice Company (NYSE: BTTR) (“Better Choice” or the “Company”), a pet health and wellness company, and its research partner, Aimia Pet HealthCo Inc. (APH), today announced that APH has signed a memorandum of understanding (MOU) with Dr. Nadia Crosignani for the development of a GLP1 supplement for pets.

Key Points: 
  • TAMPA, Fla., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Better Choice Company (NYSE: BTTR) (“Better Choice” or the “Company”), a pet health and wellness company, and its research partner, Aimia Pet HealthCo Inc. (APH), today announced that APH has signed a memorandum of understanding (MOU) with Dr. Nadia Crosignani for the development of a GLP1 supplement for pets.
  • The MOU sets out the basis for Dr. Crosignani to commence research and development of a GLP1 supplement for use in companion animals.
  • In addition, Dr. Crosignani has a post-doctorate degree from UNESP, Faculty of Medicine, researching in the field of pain management.
  • We see the use of the GLP1 supplement as a significant opportunity for the pet health industry and are assembling top tier partners to help Better Choice and our brands, including Halo, become pioneers in this sector,” commented Mike Young, Chairman of the Board for Better Choice.

Better Choice Announces Partnership with Aimia Pet Health to Develop a GLP1 Supplement for its Halo Brand to Combat Obesity in Dogs and Cats

Retrieved on: 
Thursday, October 12, 2023
Partnership, NYSE, Nutrient, Cat, Animal, Better Choice Parking, Pet, GLP1, Diabetes, Overweight, Dirlotapide, Dog, Halo, Pfizer, Human, Arthritis, Research, Dietary supplement

TAMPA, Fla., Oct. 12, 2023 (GLOBE NEWSWIRE) -- Better Choice Company (NYSE: BTTR) (“Better Choice” or “the Company”), a pet health and wellness company, today announced it has signed a research and development partnership with Aimia Pet Health to develop a GLP1 supplement for overweight pets under its Halo brand.

Key Points: 
  • TAMPA, Fla., Oct. 12, 2023 (GLOBE NEWSWIRE) -- Better Choice Company (NYSE: BTTR) (“Better Choice” or “the Company”), a pet health and wellness company, today announced it has signed a research and development partnership with Aimia Pet Health to develop a GLP1 supplement for overweight pets under its Halo brand.
  • More than half of all dogs and cats worldwide are classified as overweight or obese and can suffer from the same weight-related health complications as humans – including arthritis, diabetes, and high blood pressure.
  • Following the successful creation by Pfizer of its Slentrol medication, Better Choice will work with Aimia Pet Health to develop treats and toppers to safely combat pet obesity.
  • The goal of the research and development work is to mirror the weight loss benefits of leading brands for domestic animals and in humans including Slentrol, Wegovy, Ozempic, and Monjaro with added protein and nutrients from our halo products to promote lean muscle and overall pet health.

Better Choice Company, Inc. Announces Second Quarter 2023 Results

Retrieved on: 
Monday, August 21, 2023
Partnership, International, POS, GAAP, YOY, Sale, Direct, EBITDA, Better Choice Parking, Acquisition, Growth, Adjustment, NYSE, Retail, Tutoring, Alphia Possamai-Inesedy

TAMPA, Fla., Aug. 21, 2023 (GLOBE NEWSWIRE) -- Better Choice Company, Inc. (NYSE American: BTTR) (the “Company” or “Better Choice”), a pet health and wellness company, Friday announced its results for the second quarter ended June 30, 2023 (“Q2 2023”).

Key Points: 
  • TAMPA, Fla., Aug. 21, 2023 (GLOBE NEWSWIRE) -- Better Choice Company, Inc. (NYSE American: BTTR) (the “Company” or “Better Choice”), a pet health and wellness company, Friday announced its results for the second quarter ended June 30, 2023 (“Q2 2023”).
  • Point-of-sale (“POS”) growth and strength of digital presence drove a 14% net sales growth from the first quarter of 2023 (“Q1 2023").
  • The Direct-to-Consumer digital segment experienced 28% net sales growth in the second quarter since Q1 2023, driven by a focused customer acquisition and revised promotional strategy.
  • “The second quarter was highlighted by our gross margin improvement and step change in operational discipline,” commented newly appointed CEO of Better Choice, Kent Cunningham.

Better Choice Company Makes Its Interim CFO Permanent

Retrieved on: 
Friday, August 4, 2023
Central Florida, Interim, IPO, University, Certified Public Accountant, Better, Judgement, PwC, NYSE, Business administration, Better Choice Parking, Interim management, CFO, Growth, Martínez, Halo, Management, Assurance

NEW YORK, Aug. 04, 2023 (GLOBE NEWSWIRE) -- Better Choice Company (NYSE: BTTR) (“Better Choice” or “the Company”), a pet health and wellness company, today announced it has appointed Carolina (“Nina”) Martinez as Chief Financial Officer, giving its interim CFO the role on a permanent basis effective August 7, 2023.

Key Points: 
  • NEW YORK, Aug. 04, 2023 (GLOBE NEWSWIRE) -- Better Choice Company (NYSE: BTTR) (“Better Choice” or “the Company”), a pet health and wellness company, today announced it has appointed Carolina (“Nina”) Martinez as Chief Financial Officer, giving its interim CFO the role on a permanent basis effective August 7, 2023.
  • Nina will lead the Company’s financial strategy and function, and will report directly to Kent Cunningham, Chief Executive Officer of Better Choice.
  • “I am pleased to welcome Nina to the Better Choice executive management team,” said Cunningham.
  • We are confident that Nina’s addition as the CFO is a pivotal step in the future growth of Better Choice,” commented Michael Young, Chairman of Better Choice.

Alphia & Better Choice Announce Long Term Strategic Manufacturing Partnership

Retrieved on: 
Thursday, June 22, 2023
Growth, Partnership, Better Choice Parking, NYSE, Pet, Bottled water, Alphia Possamai-Inesedy

DENVER, June 22, 2023 /PRNewswire/ -- Alphia, Inc. , the largest custom manufacturer of super-premium pet food in the U.S., announces a long term strategic manufacturing partnership with Better Choice Company (NYSE: BTTR), a pet health and wellness company.

Key Points: 
  • DENVER, June 22, 2023 /PRNewswire/ -- Alphia, Inc. , the largest custom manufacturer of super-premium pet food in the U.S., announces a long term strategic manufacturing partnership with Better Choice Company (NYSE: BTTR), a pet health and wellness company.
  • Along with a $5M investment made by Alphia into Better Choice, Alphia will become the manufacturer for its premier brand, Halo, a high growth super-premium pet food brand found in pet specialty stores.
  • Alphia announces a long term strategic manufacturing partnership with Better Choice Company (NYSE: BTTR)
    "Solidifying a long-term manufacturing relationship with Better Choice is in line with Alphia's vision to nourish & protect pets every day, creating a lasting impact with brand partners that share our views on safe, high quality pet food" said David McLain, CEO of Alphia, "We respect the Halo™ brand, and look forward to fueling their growth to feed more pets."
  • Michael Young, Chairman of Better Choice, commented, "With this strategic investment into Better Choice as well as a multi-year manufacturing partnership with leading premium pet manufacturer, Alphia™, Better Choice is in an excellent position to grow the Halo brand with a strong partner."